|
End-of-day quote
Buenos Aires S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 20,540.00 ARS | +2.04% |
|
+1.99% | +23.22% |
| 16/09 | Sling Therapeutics raises $123 million to advance thyroid eye disease drug | RE |
| 15/09 | Amgen Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 11:30 AM |
| Market Cap | 21TCr 3,15,66100Cr 18TCr 17TCr 16TCr 29TCr 19,99000Cr 29TCr 2,04900Cr 79TCr 10,16600Cr 78TCr 77TCr 32,70300Cr | P/E 2026 * |
24.4x | P/E 2027 * | 21.9x |
|---|---|---|---|---|---|
| Enterprise Value | 25TCr 3,78,47000Cr 22TCr 21TCr 19TCr 35TCr 23,96800Cr 35TCr 2,45700Cr 95TCr 12,18900Cr 94TCr 92TCr 39,21100Cr | EV / Sales 2026 * |
6.42x | EV / Sales 2027 * | 6.07x |
| Free-Float |
99.77% | Yield 2026 * |
2.62% | Yield 2027 * | 2.76% |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| AMGN | End-of-day quote | |
Buenos Aires S.E.
| AMGND | End-of-day quote |
Last Transcript: Amgen Inc.
| 1 day | +2.04% | ||
| 1 week | +1.99% | ||
| Current month | -10.19% | ||
| 1 month | -8.34% | ||
| 3 months | +20.82% | ||
| 6 months | +19.56% | ||
| Current year | +23.22% |
| 1 week | 19,910 |  | 20,610 |
| 1 month | 19,910 | | 23,810 |
| Current year | 15,920 | | 23,810 |
| 1 year | 12,320 | | 23,810 |
| 3 years | 6,547 | | 23,810 |
| 5 years | 1,283.33 | | 23,810 |
| 10 years | 273.67 | | 23,810 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.04% | +1.99% | - | - | 21TCr | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,02800Cr | |
| -0.09% | +1.66% | +53.24% | +66.45% | 65TCr | |
| -0.02% | +2.66% | +18.65% | +71.97% | 47TCr | |
| -1.22% | +3.66% | +36.44% | +38.32% | 35TCr | |
| -0.79% | +2.73% | +19.03% | +25.08% | 27TCr | |
| +0.58% | +6.76% | +11.13% | +16.52% | 26TCr | |
| +1.55% | +2.20% | +35.12% | +45.91% | 21TCr | |
| +0.79% | +1.84% | -28.27% | -56.71% | 19TCr | |
| -0.52% | +4.45% | +31.57% | +98.11% | 19TCr | |
| Average | +0.24% | +3.26% | +25.58% | +45.13% | 40.02TCr | |
| Weighted average by Cap. | +0.08% | +3.09% | +35.12% | +61.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.89TCr 58,95300Cr 3.39TCr 3.2TCr 2.91TCr 5.45TCr 3,73300Cr 5.47TCr 38TCr 15TCr 1,89900Cr 15TCr 14TCr 6,10800Cr | 4.02TCr 60,91200Cr 3.5TCr 3.31TCr 3TCr 5.63TCr 3,85700Cr 5.65TCr 40TCr 15TCr 1,96200Cr 15TCr 15TCr 6,31100Cr |
| Net income | 867.84Cr 13,13900Cr 755.56Cr 713.2Cr 647.98Cr 1.21TCr 83TCr 1.22TCr 8.53TCr 3.29TCr 42TCr 3.26TCr 3.19TCr 1,36100Cr | 934.18Cr 14,14300Cr 813.32Cr 767.72Cr 697.51Cr 1.31TCr 90TCr 1.31TCr 9.18TCr 3.55TCr 46TCr 3.51TCr 3.43TCr 1,46500Cr |
| Net Debt | 4.15TCr 62,80900Cr 3.61TCr 3.41TCr 3.1TCr 5.8TCr 3,97800Cr 5.83TCr 41TCr 16TCr 2,02300Cr 16TCr 15TCr 6,50700Cr | 3.58TCr 54,22600Cr 3.12TCr 2.94TCr 2.67TCr 5.01TCr 3,43400Cr 5.03TCr 35TCr 14TCr 1,74600Cr 13TCr 13TCr 5,61800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | ARS 20,540.00 | +2.04% | 2,145 |
| 17/26/17 | ARS 20,130.00 | +0.60% | 658 |
| 16/26/16 | ARS 20,010.00 | +0.35% | 7,609 |
| 15/26/15 | ARS 19,940.00 | -1.87% | 1,084 |
| 14/26/14 | ARS 20,320.00 | +0.89% | 1,670 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
